Skip to main content

CORRECTION article

Front. Oncol., 15 December 2022
Sec. Thoracic Oncology
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1118042

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

This article is a correction to:

  1. Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

    1. Read original article
Wei Zhang&#x;Wei Zhang1†Weiwei Wang,&#x;Weiwei Wang1,2†Junlu Wu&#x;Junlu Wu1†Jiale TianJiale Tian1Wenhui YanWenhui Yan3Yi YuanYi Yuan1Yiwen YaoYiwen Yao4Anquan Shang*Anquan Shang1*Wenqiang Quan*Wenqiang Quan1*
  • 1Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
  • 2Department of Pathology, Tinghu People’s Hospital, Yancheng, China
  • 3Department of Laboratory Medicine, Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji Univeirsity School of Medicine, Shanghai, China
  • 4Department of Internal Medicine V-Pulmonology, Allergology, Respiratory Intensive Care Medicine, Saarland University Hospital, Homburg, Germany

A Corrigendum on
Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

by Zhang W, Wang W, Wu J, Tian J, Yan W, Yuan Y, Yao Y, Shang A and Quan W (2022) Front. Oncol. 12:942964. doi: 10.3389/fonc.2022.942964

In the published article, an author name was incorrectly written as Wenqian Quan. The correct spelling is Wenqiang Quan.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: NLR, LMR, HNR, NSCLC, risk assessment, diagnostic markers

Citation: Zhang W, Wang W, Wu J, Tian J, Yan W, Yuan Y, Yao Y, Shang A and Quan W (2022) Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis. Front. Oncol. 12:1118042. doi: 10.3389/fonc.2022.1118042

Received: 07 December 2022; Accepted: 08 December 2022;
Published: 15 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zhang, Wang, Wu, Tian, Yan, Yuan, Yao, Shang and Quan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Anquan Shang, c2hhbmdhbnF1YW5AdG9uZ2ppLmVkdS5jbg==; Wenqiang Quan, cXdxQHRvbmdqaS5lZHUuY24=

†The authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.